Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Savvas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Climacteric : the Journal of the International Menopause Society|October 11, 2021
John Studd (4th March 1940-17th August 2021)Mike Savvas, Mark Brincat
American Journal of Obstetrics and Gynecology|April 22, 2018
Premenstrual disordersJohn Studd, Mike Savvas, Neale Watson
Post Reproductive Health|October 13, 2020
The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal womenHaitham Hamoda, Nick Panay, Hugo Pedder, et al.
Human Fertility (Cambridge, England)|July 28, 2021
Socioeconomic status and fertility treatment outcomes in high-income countries: a review of the current literatureRachel Imrie, Srirupa Ghosh, Nitish Narvekar, et al.
GMS Journal for Medical Education|March 5, 2019
Is the clinician an independent variable in embryo transfer outcomes under standardized direct and indirect supervision? A 5-year observational cohort studyMonica Mittal, Prasanna Raj Supramaniam, Lee Nai Lim, et al.
Maturitas|June 10, 2022
Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trialMonica Mittal, Carmel McEniery, Prasanna Raj Supramaniam, et al.
Menopause (New York, N.Y.)|April 29, 2022
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trialMonica Mittal, Paradzai Chitongo, Prasanna Raj Supramaniam, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Climacteric : the Journal of the International Menopause Society|October 11, 2021
John Studd (4th March 1940-17th August 2021)Mike Savvas, Mark Brincat
American Journal of Obstetrics and Gynecology|April 22, 2018
Premenstrual disordersJohn Studd, Mike Savvas, Neale Watson
Post Reproductive Health|October 13, 2020
The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal womenHaitham Hamoda, Nick Panay, Hugo Pedder, et al.
Human Fertility (Cambridge, England)|July 28, 2021
Socioeconomic status and fertility treatment outcomes in high-income countries: a review of the current literatureRachel Imrie, Srirupa Ghosh, Nitish Narvekar, et al.
GMS Journal for Medical Education|March 5, 2019
Is the clinician an independent variable in embryo transfer outcomes under standardized direct and indirect supervision? A 5-year observational cohort studyMonica Mittal, Prasanna Raj Supramaniam, Lee Nai Lim, et al.
Maturitas|June 10, 2022
Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trialMonica Mittal, Carmel McEniery, Prasanna Raj Supramaniam, et al.
Menopause (New York, N.Y.)|April 29, 2022
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trialMonica Mittal, Paradzai Chitongo, Prasanna Raj Supramaniam, et al.
Pageof 1